Manish Maski is the Global Medical Head for Rare Nephrology at Sanofi Genzyme, leading and overseeing the global medical strategy and activities related to the Fabry disease, ADPKD, and Alport syndrome programs. Prior to joining Industry, Manish was an attending physician at Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School (HMS), where he still maintains a part-time faculty position and performs inpatient nephrology consultations within the BIDMC hospital system. Manish is a board-certified clinical nephrologist and is formally trained in basic, translational, and clinical research at both BIDMC and HMS. Manish lives in Brookline and has children at the Baker school.
